Daesung Microbiological Labs. Statistics

Total Valuation

Daesung Microbiological Labs. has a market cap or net worth of KRW 38.38 billion. The enterprise value is 50.89 billion.

Market Cap	38.38B
Enterprise Value	50.89B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Daesung Microbiological Labs. has 3.80 million shares outstanding. The number of shares has increased by 0.13% in one year.

Shares Outstanding	3.80M
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	38.60%
Owned by Institutions (%)	n/a
Float	2.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.60
PB Ratio	1.08
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.56
EV / Sales	2.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-45.78

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.58.

Current Ratio	2.70
Quick Ratio	1.30
Debt / Equity	0.58
Debt / EBITDA	183.43
Debt / FCF	-18.63
Interest Coverage	-2.90

Financial Efficiency

Return on equity (ROE) is -6.97% and return on invested capital (ROIC) is -2.85%.

Return on Equity (ROE)	-6.97%
Return on Assets (ROA)	-2.71%
Return on Capital (ROIC)	-2.85%
Revenue Per Employee	179.17M
Profits Per Employee	-19.42M
Employee Count	134
Asset Turnover	0.38
Inventory Turnover	1.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+0.50%
50-Day Moving Average	9,910.40
200-Day Moving Average	10,454.80
Relative Strength Index (RSI)	55.85
Average Volume (20 Days)	19,677

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daesung Microbiological Labs. had revenue of KRW 24.01 billion and -2.60 billion in losses. Loss per share was -684.24.

Revenue	24.01B
Gross Profit	2.51B
Operating Income	-2.74B
Pretax Income	-3.16B
Net Income	-2.60B
EBITDA	112.93M
EBIT	-2.74B
Loss Per Share	-684.24

Full Income Statement

Balance Sheet

The company has 8.20 billion in cash and 20.72 billion in debt, giving a net cash position of -12.51 billion or -3,292.81 per share.

Cash & Cash Equivalents	8.20B
Total Debt	20.72B
Net Cash	-12.51B
Net Cash Per Share	-3,292.81
Equity (Book Value)	35.63B
Book Value Per Share	9,377.39
Working Capital	15.49B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -136.18 million and capital expenditures -975.62 million, giving a free cash flow of -1.11 billion.

Operating Cash Flow	-136.18M
Capital Expenditures	-975.62M
Free Cash Flow	-1.11B
FCF Per Share	-292.58

Full Cash Flow Statement

Margins

Gross margin is 10.44%, with operating and profit margins of -11.40% and -10.84%.

Gross Margin	10.44%
Operating Margin	-11.40%
Pretax Margin	-13.15%
Profit Margin	-10.84%
EBITDA Margin	0.47%
EBIT Margin	-11.40%
FCF Margin	-4.63%

Dividends & Yields

Daesung Microbiological Labs. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.13%
Shareholder Yield	-0.13%
Earnings Yield	-6.77%
FCF Yield	-2.90%

Dividend Details

Stock Splits

The last stock split was on April 25, 2018. It was a forward split with a ratio of 10.

Last Split Date	Apr 25, 2018
Split Type	Forward
Split Ratio	10

Scores

Daesung Microbiological Labs. has an Altman Z-Score of 2.24. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.24
Piotroski F-Score	n/a